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Summary
Nuclear b-catenin is a transcriptional coactivator of
LEF-1/TCF DNA-binding proteins in the Wnt/Wg signal-
ing pathway [1]. Casein Kinase 2 (CK2), a positive
regulator of Wnt signaling [2–4], is present inb-catenin
complexes [5, 6] and activated in Wnt-signaling cells
[7]. We show here that CK2 enhances b-catenin:
LEF-1 transactivation in vivo and in vitro and that b-
catenin and CK2 cycle on and off the DNA in an alter-
nating manner with the TLE1 corepressor at Wnt target
genes. Interestingly, CK2 phosphorylates hLEF-1
directly and stimulates binding and transactivation
of b-catenin:LEF-1 complexes on chromatin templates
in vitro. In vitro, CK2 phosphorylation of hLEF-1
strongly enhances its affinity for b-catenin and re-
duces its affinity for TLE1. MALDI-TOF mass spectrom-
etry (MS) identified two CK2 phosphorylation sites
(S42, S61) within the amino terminus of hLEF-1, and
mutation of these sites reduced binding to b-catenin
in vitro and transactivation in vivo. Remarkably, treat-
ment of cells with TBB, a pharmaceutical inhibitor of
CK2, blocked the recruitment and cycling of b-catenin
and TLE1 at Wnt target genes in vivo. Taken together,
these data indicate that CK2 is required for the assem-
bly and cycling of Wnt-enhancer complexes in vivo.
Results and Discussion
Wnt Coregulators Cycle at Target Genes
CK2 associates tightly with nuclear b-catenin and the
Wnt transducer, Dishevelled, in Wnt-signaling cells [5, 6]
and is required for the expression of Wnt target genes
[2–7]. For determining whether CK2 is recruited with
b-catenin to Wnt-induced genes, chromatin immuno-
precipitation (ChIP) experiments were used to analyze
the endogenous c-Myc and CycD1 genes in synchro-
nized myoblast C2C12 cells treated either with lithium,
a GSK3b inhibitor that stabilizes b-catenin, or with
Wnt3A-conditioned medium (WCM). Native hLEF-1
bound constitutively to the c-Myc (Figure 1A) and CycD1
(Figure 1B) genes in C2C12 cells. By contrast, b-catenin
appeared at each gene 15–30 min after induction by
lithium and oscillated on and off the DNA at repeating
75 min intervals. CK2 was also recruited to these Wnt en-
hancers and cycled together with b-catenin and other
coactivators, including TIP60 and the FACT/SSRP1
elongation factor. No binding of LEF-1 or b-catenin was
*Correspondence: jones@salk.eduobserved at distal (5 kB) upstream sites (data not shown).
Negative-acting Wnt regulators, including the TLE1
corepressor, Mi-2, a subunit of the Mi-2/NURD complex
[8], HDAC1, and GSK3b, were also present at the DNA,
but cycled in an alternating manner with b-catenin.
Thus GSK3b, which has recently been proposed to re-
press nuclear-receptor genes [9], may also function in
the nucleus as a transcriptional repressor of Wnt genes.
The observation that b-catenin and CK2 alternate with
TLE1 for binding to the CycD1 gene was confirmed by
real-time PCR ChIP (Figure 1C) and indicates that LEF-1
cannot bind simultaneously to b-catenin and TLE1 in vivo,
consistent with previous biochemical studies [10]. A
sequential ChIP (reChIP) analysis (Figure 1D) revealed
that CK2 is present in chromatin complexes isolated
with b-catenin antibodies and confirms that these pro-
teins can bind simultaneously to Wnt-responsive genes.
Importantly, endogenous b-catenin and CK2 cycled
with similar kinetics in cells treated with Wnt3A-condi-
tioned medium (WCM) (Figure 1E), concomitant with
induction of CycD1 mRNA in these cells (Figure S1 in the
Supplemental Data available online). Importantly,
siRNA-mediated depletion of endogenous CK2 signifi-
cantly impaired b-catenin transactivation of the TOP-
FLASH reporter gene in 293 cells, as well as endogenous
c-Myc transcription in SW480 cells where Wnt signaling
is constitutively active (Figure 1F).
CK2 Phosphoryation of LEF-1 Enhances
Binding to Beta-Catenin
To test whether CK2 affects transcription directly, we
used an in vitro system in which a LEF-1 promoter
template (pBRE) was assembled into nucleosomes by
incubation with a crude Drosophila embryo S190 chro-
matin-assembly extract and purified core histones, in
the presence or absence of b-catenin and LEF-1 [11].
Interestingly, CK2 enhanced b-catenin:LEF-1 transcrip-
tion in this system (Figure 2A, top panel, compare lanes
9 and 10), and this effect was blocked by the pharma-
ceutical CK2 inhibitor 4,5,6,7-tetrabromobenzotriazole
(TBB; lane 11). As noted previously [11], b-catenin
strongly enhances binding of LEF-1 to chromatin tem-
plates (Figure 2A, bottom panel, compare lanes 6 and
9), and CK2 enhanced this effect (Figure 2A, bottom
panel, compare lanes 9 and 10; see also Figure 3). By
contrast, CK2 had no effect on Notch-enhancer-depen-
dent transcription in vitro (data not shown).
In vitro kinase assays indicated that CK2 phosphory-
lates full-length His-LEF-1 and His-LEF-1DAD, a minimal
form of LEF-1 that supports b-catenin activation, but did
not phosphorylate DNß-catenin (Figure S2A). Human
TCF4 is phosphorylated by CK2 at N-terminal residues
S58, S59, and S60, which lowers its affinity for plakoglo-
bin (g-catenin) [12]. Although only one of these residues
(corresponding to S67) is conserved in human LEF-1,
protein analysis of CK2-phosphorylated His-LEF-1DAD
by MALDI-TOF mass spectrometry revealed mono-,
di-, and tri-phosphorylation of an N-terminal peptide
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(A and B) ChIP analysis of the c-Myc (A) and CycD1 (B) genes in synchronized C2C12 cells treated with LiCl for the times indicated.
(C) Quantitative analysis of the binding of b-catenin, CK2, and TLE1 to the CycD1 gene by real-time PCR.
(D) A sequential ChIP (re-ChIP) analysis of binding of b-catenin and CK2 to the CycD1 gene is shown.
(E) Cycling of Wnt coactivators at the CycD1 gene in C2C12 cells exposed to Wnt3A-conditioned medium for the different times indicated.
(F) Analysis of b-catenin transactivation of the TOPFLASH reporter gene in 293 cells (left panel) or of endogenous CycD1 transcription in SW480
CRC cells. Where indicated, cells were depleted of endogenous CK2 by treatment with si-CK2aRNA or with a nonspecific control siRNA (si-con-
RNA). The error bars are based on the standard deviations of triplicate experiments.(aa 37–74, Figure 2B), which includes S67 as well as two
series (S42 and S61) that lie within an acidic environment
typical of CK2 sites. In vitro kinase assays with mutant
His-LEF-1DAD proteins containing either single (S42A,
S61A) or double (S42A:S61A) substitutions indicate
that both S42 and S61 are key CK2 phosphorylation
sites in vitro (Figure 2C).
The observation that CK2 phosphorylates at least two
residues (S42 and S61) within the LEF-1–b-catenininteraction domain led us to examine whether it influ-
ences binding to b-catenin. First, purified GST-b-catenin
was coupled to glutathione-S-agarose beads and incu-
bated with purified untreated or CK2-phosphorylated
wild-type or mutant S42A:S61A His-LEF-1DAD proteins
in GST pull-down experiments. As shown in Figure 3A,
CK2 strongly enhanced the binding of b-catenin to
wild-type (compare lanes 5 and 6), but not mutant
S42A:S61A (compare lanes 3 and 4), His-LEF-1DAD
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His-LEF-1 to GST-b-catenin (Figure 3B, compare lanes
3 and 4). A triple-point mutation affecting S42, S61, and
S67 was as defective as the S42A:S61A mutant in its
ability to respond to CK2 (Figure S2C), whereas a sin-
gle-point mutation affecting S42, a double mutation
affecting S61 and S67, and other mutations retained
the ability to be activated by CK2 in vitro (Figures S2B
and S2C). Thus CK2 phosphorylates LEF-1 at Ser-42
and Ser-61 to increase its affinity for b-catenin and chro-
matin templates in vitro.
Figure 2. CK2 Enhances Transcription and Chromatin-Binding
Activity of LEF-1:b-Catenin In Vitro
(A) Analysis of the transcriptional activity (primer extension, upper
panel) and DNA binding (DNase I footprint, lower panel) of LEF-1
and b-catenin to chromatin-assembled pBRE templates in vitro.
The a-globin gene (a-glo) was a nonchromatin control.
(B) MALDI-TOF mass-spectrometry identification of a CK2-phos-
phorylated LEF-1 peptide.
(C) Analysis of the ability of wild-type LEF-1DAD, or various mutant
LEF-1DAD proteins, to be phosphorylated by CK2 in vitro.Interestingly, b-catenin and the Gro/TLE1 corepressor
compete for partially overlapping interaction sites within
the central and high-mobility group (HMG) domains of
LEF-1 [10]. Because this region contains multiple poten-
tial CK2 phosphorylation sites, we tested whether CK2
might affect binding of LEF-1 to Gro/TLE1. FLAG-tagged
Drosophila Groucho protein, purified from Drosophila
S2 cells [13], was coupled to M2 FLAG-agarose beads
and used in pull-down assays with the recombinant
full-length His-LEF-1 protein. In these experiments,
His-LEF-1 bound avidly to either unphosphorylated or
CK2-phosphorylated FLAG-Gro beads (Figure 3C, com-
pare lanes 3 and 4 with lanes 5 and 7). By contrast, CK2
phosphorylation of LEF-1 strongly blocked binding to
both unphosphorylated and CK2-phosphorylated
FLAG-Gro proteins (compare lane 5 with 6 and lane 7
with 8, respectively). Both wild-type and S42A:S61A
LEF-1DAD proteins bound only weakly to Groucho;
however, this interaction was nevertheless inhibited by
CK2 (Figure S3), indicating that CK2 phosphorylates
the TLE1 binding region of LEF-1DAD. Importantly,
CK2 failed to stimulate transcription (Figure 3D, top
panel, compare lanes 3 and 4) or chromatin binding
(Figure 3D, bottom panel, compare lanes 3 and 4) of
the mutant S42A:S61A His-LEF-1DAD protein in vitro.
LEF-1 N-Terminal Residues S42 and S61 Facilitate
Transactivation In Vivo
For determining whether LEF-1 activity requires S42 and
S61, Raji B cells were cotransfected with the TOPFLASH
reporter, an activated b-catenin (S33Y), and FLAG-
tagged wild-type or S42A:S61A mutant LEF-1 con-
structs, and TOPFLASH reporter-gene activity was mon-
itored relative to a TK-Renilla luciferase control plasmid.
As shown in Figure 3E, b-catenin activity was signifi-
cantly higher when coexpressed with wild-type LEF-1
than with the S42A:S61A mutant LEF-1 protein. Immuno-
blot analysis confirmed that the wild-type and S42A:
S61A mutant LEF-1 proteins were equivalently ex-
pressed in the cells, indicating that the predominant
N-terminal CK2 phosphorylation sites in LEF-1 are
required for transactivation in vivo and in vitro.
CK2 is Required for Recruitment and Cycling
of Wnt Coregulators at Target Genes
These data lead us to consider whether CK2 is required
for targeting of b-catenin to Wnt target genes in vivo.
Moreover, CK2 phosphorylation of TLE1 is required for
its repressive activity and association with chromatin
[14, 15]. Consequently, we reasoned that CK2 might
regulate the binding of both b-catenin and TLE1 to Wnt
target genes. To examine this possibility, we carried
out ChIP analyses of the CycD1 gene in cells treated
with the CK2 inhibitor, TBB, or control dimethyl sulfox-
ide (DMSO), for 1 hr prior to lithium induction of b-cate-
nin. As shown in Figure 4A, recruitment of b-catenin to
the CycD1 gene was dramatically impaired in cells
treated with TBB. Similarly, the level of TLE1 at the
CycD1 promoter before and after lithium induction was
greatly reduced in the presence of TBB (Figure 4B). By
contrast, TBB had no effect on binding of LEF-1 (Fig-
ure 4C). Induction of CycD1 transcription by lithium
was strongly blocked by TBB (Figure 4D), which did
not alter b-catenin or TLE1 levels in the nucleus
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2242Figure 3. CK2 Enhances Binding of LEF-1 to b-Catenin and Blocks Binding to Gro/TLE1 In Vitro
(A) Untreated or CK2-phosphorylated mutant (S42A:S61A; lanes 3 and 4) or wild-type (lanes 5–8) LEF-1DAD proteins were analyzed for binding to
GST-b-catenin in vitro.
(B) Binding of untreated or CK2-phosphorylated full-length His-LEF-1 to GST-b-catenin in vitro.
(C) Binding of untreated or CK2-phosphorylated full-length His-LEF-1 to unphosphorylated or CK2-phosphorylated FLAG-Gro beads in vitro.
(D) The mutant (S42A:S61A) LEF-1DAD protein is not activated by CK2 in vitro.
(E) The TOPFLASH reporter gene was transfected into Raji cells together with vectors expressing wild-type or mutant (S42A:S61A) FLAG-LEF-1,
and b-catenin, as indicated. Insert shows protein expression by immunoblot. The error bars are based on the standard deviations of triplicate
experiments.(Figure 4E). A more extensive ChIP analysis revealed
that TBB also blocks the cycling of b-catenin at the
CycD1 gene (Figure 4F), indicating that CK2 is required
for assembly and turnover of Wnt-enhancer complexes
in vivo.
The finding that CK2 phosphorylates LEF-1 and en-
hances binding to b-catenin, while blocking binding to
TLE1, indicated that it might regulate the assembly of ac-
tive Wnt enhancers. In this respect, CK2 would function
oppositely to CK1, which promotes binding of b-catenin
to the APC tumor suppressor, disfavors binding to LEF-
1/TCF proteins [16–18], and thereby inhibiting Wnt sig-
naling. Thus CK1 and CK2 may control, in opposite
ways, the switching of b-catenin and Gro/TLE1 on the
LEF-1/TCF platform. LEF-1 residues S42, S61, and S67
are highly conserved, and TCF proteins contain multiple
serine and acidic residues in the vicinity of this region,
suggesting that activation by CK2 may be conserved
among LEF/TCF family members. Interestingly, X-ray
crystallography studies indicate that the interaction ofb-catenin with E-cadherin, which closely resembles its
interaction with TCF4, is similarly enhanced by CK2
phosphorylation [19]. Remarkably, this region of LEF-1
is frequently mutated in human sebaceous-gland tumors
[20], which express a mutant LEF-1(E45K:S61P) protein
that is unable to interact with b-catenin. Our findings
suggest that the reduced affinity of the mutant LEF-1
(E45K:S61P) protein for b-catenin may arise, in part,
from its inability to be phosphorylated by CK2.
It is notable that b-catenin and associated coactiva-
tors, including CK2 and FACT, are recruited in a cyclic
manner to Wnt-responsive genes. In yeast, CK2 associ-
ates with Polymerase-associated Factor 1 (Paf1) and
FACT complexes [21]. The observation thatb-catenin as-
sociates with the Paf1 subunit, Parafibromin [22], and
with Trithorax-related MLL1/2 complexes, to promote
histone H3K4 trimethylation in vivo [23] suggests that
CK2 might also stimulate transcription elongation at Wnt
genes. Moreover, the ability of the wild-type APC tumor
suppressor, but not cancer-associated APC mutant
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2243Figure 4. CK2 Is Required for Recruitment of b-Catenin and TLE1 to the CycD1 Gene In Vivo
(A–C)Synchronized C2C12 cells were stimulated with LiCl for the various amounts of time and analyzed by real-time PCR ChIP for (A) b-catenin,
(B) TLE1, and (C) LEF-1, with or without TBB.
(D) TBB blocks b-catenin transactivation of the TOPFLASH reporter gene in 293 cells and induction of CycD1 transcription in lithium-treated cells.
(E) TBB does not affect b-catenin protein levels by immunoblot.
(F) TBB blocks the recruitment and cycling of b-catenin at the CycD1 promoter in lithium-treated C2C12 cells, as determined by quantitative real-
time PCR ChIP.
The error bars are based on the standard deviations of triplicate experiments.proteins, to bind and inhibit CK2 [24] suggests an addi-
tional mechanism by which APC may counteract b-cate-
nin transactivation in vivo. It is interesting to speculate
that the repetitive cycling of Wnt coregulator complexes
might contribute to the oscillating pattern of Wnt gene
transcription that is observed during somitogenesis,
where Wnt and Notch target genes are under the control
of the vertebrate segmentation clock [25]. We note that
CK2, CK1, and GSK3b also control circadian gene tran-
scription and that inhibition of CK2 abolishes transcript
cycling from these genes in vivo [26]. Thus further studies
are needed to assess whether cyclic coregulator recruit-
ment may regulate cyclic transcription, as well as cross-
talk among these diverse signaling pathways.
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